No price series to chart for SGMOQ.
SGMOQ is not in the screener universe; fundamentals are unavailable.
No price history for SGMOQ — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
No return history for SGMOQ, so risk analytics are unavailable.
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| AMGN | AMGEN INC | $212.16B | 27.6 |
| GILD | GILEAD SCIENCES, INC. | $166.77B | 19.8 |
| RVMD | Revolution Medicines, Inc. | $39.09B | — |
| BIIB | BIOGEN INC. | $30.36B | 23.4 |
| MRNA | Moderna, Inc. | $22.14B | — |
| NBIX | NEUROCRINE BIOSCIENCES INC | $18.38B | 39.1 |
| EXEL | EXELIXIS, INC. | $14.20B | 20.3 |
| TECH | BIO-TECHNE Corp | $11.28B | 156.7 |
| KRYS | Krystal Biotech, Inc. | $10.74B | 53.3 |
| HALO | HALOZYME THERAPEUTICS, INC. | $9.90B | 32.6 |
| QGEN | QIAGEN N.V. | $9.17B | — |
| KYMR | Kymera Therapeutics, Inc. | $8.73B | — |
